Takeda

Pharmaceutical ManufacturingTokyo, Japan10001+ Employees

Takeda is a large pharmaceutical manufacturer based in Tokyo, Japan, with a history spanning more than two centuries. The company pursues a core purpose of improving patient outcomes through medical science, guided by enduring values that prioritize patients and society. It emphasizes listening to patients, their families, and healthcare professionals to address what matters most in care. In June 2026, the U.S. FDA accepted Takeda's supplemental Biologics License Application for intravenous vedolizumab to treat moderately to severely active ulcerative colitis and Crohn's disease in pediatric patients 2 years and older. The company has publicized pivotal study results related to oveporexton, an orexin receptor 2 agonist, for narcolepsy type 1, illustrating ongoing development across multiple therapeutic areas.

Sign up for free to view info

Email Format Employee directory